Karyopharm Therapeutics (KPTI) Earnings Dates, Call Summary & Reports

The P/E ratio of {name} is N/A.

3 Followers

Earnings Data

Report Date

Oct 29, 2026

TBA (Confirmed)

Period Ending

2026 (Q3)

Consensus EPS Forecast

-0.77

Last Year’s EPS

-3.1

Same Quarter Last Year

Moderate Buy

Based on 6 Analysts Ratings

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:KPTI Upcoming Earnings

Karyopharm Therapeutics's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2026	2026 (Q3)	-0.77 / -	-3.098	―	―	―
Aug 13, 2026	2026 (Q2)	-1.11 / -1.88	-3.504	46.30% (+1.62)
May 14, 2026	2026 (Q1)	-1.15 / -1.01	-2.247	55.23% (+1.24)
Feb 12, 2026	2025 (Q4)	-1.62 / -4.63	-2.92	-58.61% (-1.71)
Nov 03, 2025	2025 (Q3)	-2.81 / -3.10	-3.163	2.05% (+0.06)
Aug 11, 2025	2025 (Q2)	-3.31 / -3.50	-2.433	-44.00% (-1.07)
May 12, 2025	2025 (Q1)	-3.58 / -2.25	-3.893	42.29% (+1.65)
Feb 19, 2025	2024 (Q4)	-3.18 / -2.92	-4.38	33.33% (+1.46)
Nov 05, 2024	2024 (Q3)	-3.20 / -3.16	-3.65	13.33% (+0.49)
Aug 06, 2024	2024 (Q2)	-3.62 / -2.43	-3.528	31.03% (+1.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

When does Karyopharm Therapeutics (CH:KPTI) report earnings?

Karyopharm Therapeutics (CH:KPTI) is schdueled to report earning on Oct 29, 2026, TBA (Confirmed).

What is Karyopharm Therapeutics (CH:KPTI) earnings time?

Karyopharm Therapeutics (CH:KPTI) earnings time is at Oct 29, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Karyopharm Therapeutics stock?

The P/E ratio of Karyopharm Therapeutics is N/A.

What is CH:KPTI EPS forecast?

CH:KPTI EPS forecast for the fiscal quarter 2026 (Q3) is -0.77.